Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study

Natoli, L., Guy, R. J., Shephard, M., Whiley, D., Tabrizi, S. N., Ward, J., Regan, D. G., Badman, S. G., Anderson, D. A., Kaldor, J. and Maher, L. (2015) Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. Bmj Open, 5 4: 1-8. doi:10.1136/bmjopen-2014-006922


Author Natoli, L.
Guy, R. J.
Shephard, M.
Whiley, D.
Tabrizi, S. N.
Ward, J.
Regan, D. G.
Badman, S. G.
Anderson, D. A.
Kaldor, J.
Maher, L.
Title Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study
Journal name Bmj Open   Check publisher's open access policy
ISSN 2044-6055
Publication date 2015-04-28
Sub-type Article (original research)
DOI 10.1136/bmjopen-2014-006922
Open Access Status DOI
Volume 5
Issue 4
Start page 1
End page 8
Total pages 8
Language eng
Formatted abstract
Objectives: With accurate molecular tests now available for diagnosis of chlamydia and gonorrhoea (Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG)) at the point-of-care (POC), we aimed to explore the public health implications (benefits and barriers) of their integration into remote primary care in Australia.

Methods: Qualitative interviews were conducted with a purposively selected group of 18 key informants reflecting sexual health, primary care, remote Aboriginal health and laboratory expertise.

Results: Participants believed that POC testing may decrease community prevalence of sexually transmitted infections (STIs), and associated morbidity by reducing the time to treatment and infectious period and expediting partner notification. Also, POC testing could improve acceptability of STI testing, increase testing coverage and result in more targeted prescribing, thereby minimising the risk of antibiotic resistance. Conversely, some felt the immediacy of diagnosis could deter certain young people from being tested. Participants also noted that POC testing may reduce the completeness of communicable disease surveillance data given the current dependence on reporting from pathology laboratories. Others expressed concern about the need to maintain and improve the flow of NG antibiotic sensitivity data, already compromised by the shift to nucleic acid-based testing. This is particularly relevant to remote areas where culture viability is problematic.

Conclusions: Results indicate a high level of support from clinicians and public health practitioners for wider access to CT/NG POC tests citing potential benefits, including earlier, more accurate treatment decisions and reductions in ongoing transmission. However, the data also highlight the need for new systems to avoid adverse impact on disease surveillance.

Trial registration number: Australian and New Zealand Clinical Trials Registry: ACTRN12613000808741.
Keyword Sexually transmitted infections
Neisseria gonorrhoeae
Aboriginal communities
Syndromic management
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2016 Collection
School of Medicine Publications
Child Health Research Centre Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 21 Jun 2015, 01:18:02 EST by System User on behalf of Scholarly Communication and Digitisation Service